- Featured Product
- KD/KO Validated
SETD7 Polyklonaler Antikörper
SETD7 Polyklonal Antikörper für WB, IF/ICC, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, IF/ICC, CoIP, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 24840-1-AP
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in WB | HeLa-Zellen, C6-Zellen, Maushirngewebe, Mausnierengewebe, NIH/3T3-Zellen, Rattenhirngewebe |
| Erfolgreiche Detektion in IF/ICC | HeLa-Zellen |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:5000 |
| Immunfluoreszenz (IF)/ICC | IF/ICC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Veröffentlichte Anwendungen
| KD/KO | See 3 publications below |
| WB | See 8 publications below |
| IHC | See 2 publications below |
| CoIP | See 2 publications below |
Produktinformation
24840-1-AP bindet in WB, IHC, IF/ICC, CoIP, ELISA SETD7 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| In Publikationen genannte Reaktivität | human, Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | SETD7 fusion protein Ag18219 |
| Vollständiger Name | SET domain containing (lysine methyltransferase) 7 |
| Berechnetes Molekulargewicht | 366 aa, 41 kDa |
| Beobachtetes Molekulargewicht | 48-50 kDa |
| GenBank-Zugangsnummer | BC121055 |
| Gene symbol | SETD7 |
| Gene ID (NCBI) | 80854 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS with 0.02% sodium azide and 50% glycerol |
| Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
SET domain containing lysine methyltransferase 7 (SETD7, also called SET7/9) was the first lysine methyltransferase (KMT) discovered to specifically monomethylate lysine-4 of histone 3 (H3K4me1) (PMID: 26435321). SETD7 has been shown to have a very broad target specificity in vitro, including transcriptional regulators such as TAF10, p53, ER, p65, STAT3, Rb, Mypt, Tat, and Foxo3 (PMID: 25136132, 30013796).
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| WB protocol for SETD7 antibody 24840-1-AP | Protokoll herunterladen |
| IF protocol for SETD7 antibody 24840-1-AP | Protokoll herunterladen |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
| Species | Application | Title |
|---|---|---|
EBioMedicine Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients. | ||
Oncotarget SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis.
| ||
FASEB J SETD7 mediates the vascular invasion in articular cartilage and chondrocytes apoptosis in osteoarthriis. | ||
Exp Cell Res Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells | ||
Med Oncol DDB1 regulates the activation-induced apoptosis of T cells via downregulating the expression of histone methyltransferase SETD7 | ||
Histol Histopathol ZKSCAN5 activates LAPTM5 expression by recruiting SETD7 to promote metastasis in pancreatic ductal adenocarcinoma |




